Chembio Receives Emergency Use Authorization for Zika Test
FDA has granted Chembio Diagnostics emergency use authorization for its DPP Zika system.
Read MorePosted by Cassandra Perez | Oct 30, 2017 | Emerging & Zoonotic Diseases, Infectious Diseases |
FDA has granted Chembio Diagnostics emergency use authorization for its DPP Zika system.
Read MorePosted by Cassandra Perez | Oct 30, 2017 | Lab Automation, Microbiology, Research |
LBT Innovations and Clever Culture Systems have installed their APAS Independence automated microbiology instrument at St Vincent’s Hospital, Melbourne, to begin its first global evaluation in situ.
Read MorePosted by Cassandra Perez | Oct 30, 2017 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics, Respiratory Disease |
ARUP Laboratories and IDbyDNA have announced the launch of Explify Respiratory, a next-generation sequencing test for respiratory infections.
Read MorePosted by Elaine Sanchez Wilson | Oct 3, 2017 |
New features have been added to the company’s Access 2 immunoassay system to improve ease of use, workflow efficiencies, system reliability, and customer satisfaction.
Read MorePosted by Elaine Sanchez Wilson | Sep 19, 2017 | Uncategorized |
Funds will be used to support ongoing and new clinical trials, scale up laboratory capacity, and advance commercialization of the Karius test, designed to enable the broad and rapid detection of more than 1,250 pathogens.
Read More